BIOMAT Database Logo BIOMAT Database Logo

Response of immunoreactive parathyroid hormone to intravenous phosphate infusion in primary hyperparathyroidism. 1974

U Binswanger, and J A Fischer

UI MeSH Term Description Entries
D006961 Hyperparathyroidism A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.
D006996 Hypocalcemia Reduction of the blood calcium below normal. Manifestations include hyperactive deep tendon reflexes, Chvostek's sign, muscle and abdominal cramps, and carpopedal spasm. (Dorland, 27th ed) Hypocalcemias
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010281 Parathyroid Hormone A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates. Natpara,PTH (1-84),PTH(1-34),Parathormone,Parathyrin,Parathyroid Hormone (1-34),Parathyroid Hormone (1-84),Parathyroid Hormone Peptide (1-34),Hormone, Parathyroid
D010710 Phosphates Inorganic salts of phosphoric acid. Inorganic Phosphate,Phosphates, Inorganic,Inorganic Phosphates,Orthophosphate,Phosphate,Phosphate, Inorganic
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

U Binswanger, and J A Fischer
Response to parathyroid hormone infusion in primary hyperparathyroidism.
April 1968, The Journal of clinical endocrinology and metabolism,
U Binswanger, and J A Fischer
Immunoreactive forms of circulating parathyroid hormone in primary and ectopic hyperparathyroidism.
July 1974, The Journal of clinical investigation,
U Binswanger, and J A Fischer
Failure of cimetidine to suppress immunoreactive parathyroid hormone and hypercalcaemia in primary hyperparathyroidism.
April 1981, Postgraduate medical journal,
U Binswanger, and J A Fischer
Parathyroid hormone and calcitonin response during the calcium infusion test in patients with primary hyperparathyroidism.
June 2022, Hormones (Athens, Greece),
U Binswanger, and J A Fischer
Characterization of the molecular forms of immunoreactive parathyroid hormone in primary hyperparathyroidism and in hyperparathyroidism due to renal failure.
November 1983, Scandinavian journal of clinical and laboratory investigation,
U Binswanger, and J A Fischer
Radioimmunoassay of parathyroid hormone: peripheral plasma immunoreactive parathyroid hormone response to ethylenediaminetetraacetate.
September 1974, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
U Binswanger, and J A Fischer
Intact parathyroid hormone in primary hyperparathyroidism.
February 1990, The British journal of surgery,
U Binswanger, and J A Fischer
Parathyroid hormone secretion in primary hyperparathyroidism.
August 1977, The Journal of clinical endocrinology and metabolism,
U Binswanger, and J A Fischer
Effects of parathyroid hormone infusion and primary hyperparathyroidism on serum prolactin in man.
August 1980, The Journal of clinical endocrinology and metabolism,
U Binswanger, and J A Fischer
Suppressibility of parathyroid hormone in primary hyperparathyroidism.
January 2007, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
Copied contents to your clipboard!